117 related articles for article (PubMed ID: 2913269)
21. Comparative nephrotoxicity and tissue accumulation of dactimicin, amikacin and gentamicin.
Bonadio M; Maccanti O; Giovannini L; Bertelli AA; Scalori V; Alessandrì MG; Bertelli A
Drugs Exp Clin Res; 1987; 13(12):747-50. PubMed ID: 3447878
[TBL] [Abstract][Full Text] [Related]
22. Protective effect of ebselen, a selenoorganic drug, against gentamicin-induced renal damage in rats.
Dhanarajan R; Abraham P; Isaac B
Basic Clin Pharmacol Toxicol; 2006 Sep; 99(3):267-72. PubMed ID: 16930301
[TBL] [Abstract][Full Text] [Related]
23. Comparative effects of selective and non-selective nitric oxide synthase inhibition in gentamicin-induced rat nephrotoxicity.
Ghaznavi R; Kadkhodaee M
Arch Toxicol; 2007 Jun; 81(6):453-7. PubMed ID: 17039356
[TBL] [Abstract][Full Text] [Related]
24. Increased gentamicin nephrotoxicity in normal and diseased dogs administered identical serum drug concentration profiles: increased sensitivity in subclinical renal dysfunction.
Frazier DL; Dix LP; Bowman KF; Thompson C; Riviere JE
J Pharmacol Exp Ther; 1986 Dec; 239(3):946-51. PubMed ID: 3795053
[TBL] [Abstract][Full Text] [Related]
25. Protective effect of lycopene on gentamicin-induced oxidative stress and nephrotoxicity in rats.
Karahan I; Ateşşahin A; Yilmaz S; Ceribaşi AO; Sakin F
Toxicology; 2005 Nov; 215(3):198-204. PubMed ID: 16125832
[TBL] [Abstract][Full Text] [Related]
26. Nephrotoxicity of lysine and of a single dose of aminoglycoside in rats given lysine.
Malis CD; Racusen LC; Solez K; Whelton A
J Lab Clin Med; 1984 May; 103(5):660-76. PubMed ID: 6425441
[TBL] [Abstract][Full Text] [Related]
27. Dose response studies of gentamicin nephrotoxicity in rats with experimental renal dysfunction. III. Effects of dosage adjustment method.
Rogers RA; Hanna AY; Riviere JE
Res Commun Chem Pathol Pharmacol; 1987 Sep; 57(3):301-11. PubMed ID: 3671882
[TBL] [Abstract][Full Text] [Related]
28. A potential role for angiotensin II in obesity induced cardiac hypertrophy and ischaemic/reperfusion injury.
du Toit EF; Nabben M; Lochner A
Basic Res Cardiol; 2005 Jul; 100(4):346-54. PubMed ID: 15821998
[TBL] [Abstract][Full Text] [Related]
29. Age-dependent gentamicin experimental nephrotoxicity.
Beauchamp D; Gourde P; Thériault G; Bergeron MG
J Pharmacol Exp Ther; 1992 Feb; 260(2):444-9. PubMed ID: 1738093
[TBL] [Abstract][Full Text] [Related]
30. [Can gentamicin nephrotoxicity in rats be modified by chronic administration of muzolimine?].
Toutain H; Olier B; Fillastre JP; Morin JP
Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):582-6. PubMed ID: 3534747
[TBL] [Abstract][Full Text] [Related]
31. Diallyl sulfide enhances antioxidants and inhibits inflammation through the activation of Nrf2 against gentamicin-induced nephrotoxicity in Wistar rats.
Kalayarasan S; Prabhu PN; Sriram N; Manikandan R; Arumugam M; Sudhandiran G
Eur J Pharmacol; 2009 Mar; 606(1-3):162-71. PubMed ID: 19374873
[TBL] [Abstract][Full Text] [Related]
32. Influence of muzolimine, a new diuretic, on experimental gentamicin nephrotoxicity.
Toutain H; Olier B; Fillastre JP; Morin JP
Nephrol Dial Transplant; 1987; 2(6):520-5. PubMed ID: 3126452
[TBL] [Abstract][Full Text] [Related]
33. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
[TBL] [Abstract][Full Text] [Related]
34. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
35. Obesity as a risk factor in drug-induced organ injury. III. Increased liver and kidney injury by furosemide in the obese overfed rat.
Corcoran GB; Salazar DE; Chan HH
Toxicol Appl Pharmacol; 1989 Mar; 98(1):12-24. PubMed ID: 2467406
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of renal membrane binding and nephrotoxicity of gentamicin by polyasparagine and polyaspartic acid in the rat.
Williams PD; Hottendorf GH
Res Commun Chem Pathol Pharmacol; 1985 Feb; 47(2):317-20. PubMed ID: 3838817
[TBL] [Abstract][Full Text] [Related]
37. Gentamicin nephropathy and contrast media. A comparison between diatrizoate and iohexol in rats.
Thomsen HS; Skaarup P; Larsen S; Golman K; Hemmingsen L
Acta Radiol; 1990 Jul; 31(4):401-7. PubMed ID: 1976338
[TBL] [Abstract][Full Text] [Related]
38. Comparative nephrotoxicity of gentamicin and netilmicin: functional and morphological correlations with urinary enzyme activities.
Adelman RD; Conzelman G; Spangler W; Ishizaki G
Curr Probl Clin Biochem; 1979; (9):166-82. PubMed ID: 446071
[TBL] [Abstract][Full Text] [Related]
39. Comparative study of aminoglycoside nephrotoxicity in normal rats and rats with experimental cirrhosis.
Camps J; Sola X; Rimola A; Parés A; Rives A; Salmeron JM; Arroyo V; Rodés J
Hepatology; 1988; 8(4):837-44. PubMed ID: 3391510
[TBL] [Abstract][Full Text] [Related]
40. Gentamicin-induced ototoxicity and nephrotoxicity vary with circadian time of treatment and entail separate mechanisms.
Blunston MA; Yonovitz A; Woodahl EL; Smolensky MH
Chronobiol Int; 2015; 32(9):1223-32. PubMed ID: 26506922
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
